Living with AS in Australia
AS care in Australia combines Medicare-funded specialist care with the PBS for biologic access. Understanding the Pharmaceutical Benefits Scheme is key.
Getting a diagnosis
Your GP can refer you to a rheumatologist under Medicare. If you have private health insurance with extras cover, you can self-refer.
Diagnostic delays in Australia mirror global patterns — average 7+ years. Ask for HLA-B27 testing and MRI of sacroiliac joints. Name the term "axial spondyloarthritis" — it is the current clinical term that covers both AS and non-radiographic axSpA.
Arthritis Australia (arthritisaustralia.com.au) has resources and can connect you with advocacy support.
Biologics on the PBS
The Pharmaceutical Benefits Scheme funds biologics for AS after two NSAIDs have failed and BASDAI is 4+ (or equivalent functional criteria). Your rheumatologist applies for PBS Authority listing.
Approved biologics include adalimumab (Humira/biosimilars), etanercept, certolizumab, golimumab, secukinumab, and ixekizumab. Biosimilars are equally effective and widely used.
Without PBS coverage, biologics cost $15,000–$30,000/year. With PBS, the patient contribution is capped (2025: ~$31.60 per script for general patients, ~$7.70 for concession).
Disability support
AS may qualify you for the Disability Support Pension (DSP) if it substantially reduces your capacity to work. Assessed by Services Australia.
The National Disability Insurance Scheme (NDIS) is relevant for some people with AS depending on functional impact and age — under 65 at application.
Sickness Allowance (now JobSeeker with a medical certificate) is available during temporary incapacity.
Workplace rights
The Disability Discrimination Act 1992 requires employers to make reasonable adjustments for AS. Flexible work arrangements, modified duties, and ergonomic adjustments are all covered.
If your employer refuses a reasonable adjustment, you can complain to the Australian Human Rights Commission.